Australian brown snakes undergo a dramatic transformation as they grow, and new research suggests that the change is written directly into the activity of their venom glands. A study published in BMC Biology has found that several species switch from producing predominantly neurotoxic venom as juveniles to manufacturing a powerful blood-disrupting cocktail as adults. The shift coincides with a major change in diet: young snakes primarily hunt reptiles, while larger adults increasingly target mammals. Rather than being a simple increase in venom quantity or potency, the transition appears to involve the coordinated activation of four separate toxin gene families. Together, these molecular changes remodel the venom from a weapon that attacks the nervous system into one that rapidly interferes with the blood-clotting machinery of mammalian prey. The finding offers an unusually clear example of development, gene regulation and ecology converging in a single biological adaptation.
Australian brown snakes belong to the genus Pseudonaja, a group responsible for some of the most medically significant snakebites in Australia. Their venom is already renowned for its ability to produce severe, sometimes fatal effects in humans, but the new study shows that venom composition is not fixed throughout the animal’s life. Instead, it changes in a predictable developmental sequence. Hatchlings and other young snakes possess venom dominated by neurotoxins, molecules that interfere with communication between nerves and muscles. These toxins can prevent normal nerve signalling, potentially causing paralysis in small reptilian prey. As the snakes mature, however, the venom glands begin expressing high levels of procoagulant toxins. These compounds accelerate key steps in the coagulation cascade, the tightly regulated chain of enzymatic reactions that normally seals damaged blood vessels. In mammalian prey, the result can be catastrophic: blood rapidly loses its ability to clot in a controlled way, and the entire circulatory system becomes destabilized.
The researchers identified four principal procoagulant toxin families involved in the adult phenotype. They include venom versions of coagulation factors V and X, group I phospholipase A₂ enzymes and Kunitz-type serine protease inhibitors. In healthy blood, factor X is part of the molecular machinery that helps generate thrombin, the enzyme responsible for converting soluble fibrinogen into insoluble fibrin, the protein mesh that forms a clot. Factor V acts as a cofactor, dramatically increasing the efficiency of this reaction. When related proteins are delivered through venom in an uncontrolled manner, they can activate clotting at extraordinary speed. Phospholipase A₂ toxins can damage cell membranes and influence platelet and inflammatory pathways, while Kunitz-type proteins can modify protease activity and contribute to the venom’s broader effects on coagulation. The adult brown snake therefore does not rely on one isolated molecule. It deploys a coordinated biochemical system capable of attacking several connected points in the mammalian clotting network.
This distinction is important because venom evolution is often described in terms of individual toxins gaining or losing activity. The Australian brown snake findings point to a different mechanism: a developmental program that changes the expression of multiple genes at once. The genes encoding the four procoagulant toxin groups are largely absent from the venom profiles of juvenile snakes, but become collectively expressed in adults. The venom gland, a specialized secretory organ, functions like a highly regulated molecular factory. Its cells transcribe toxin genes into messenger RNA, translate those instructions into proteins and then package the finished molecules into venom. By comparing toxin transcripts, venom proteins and functional assays, the researchers connected gene activity to the chemical composition of venom and finally to its biological effect. This chain of evidence is significant because it moves beyond simply cataloguing venom molecules. It demonstrates how a change in gene regulation can produce a new physiological weapon with direct consequences for survival.
The timing of the venom transformation tracks a broader ecological transition. Young brown snakes are small, slender animals that generally encounter prey such as lizards and other reptiles. Their neurotoxic venom is well suited to immobilizing these animals, whose physiology and body size differ substantially from those of mammals. As snakes grow, their hunting opportunities change. Larger bodies allow them to overpower and consume mammalian prey, including animals that may be more difficult to subdue and whose blood-clotting systems can be exploited by procoagulant venom. The researchers found that the emergence of adult-type venom activity coincides with the point at which brown snakes begin feeding on mammals. This correlation does not prove that the prey switch alone triggers toxin expression, but it strongly supports the idea that development has been shaped around changing ecological demands. Venom, in this case, is not merely a defensive secretion. It is an extended phenotype, a biological trait produced by the animal that reaches beyond its body to influence the environment and its prey.
The study also included a natural comparison that strengthens the evolutionary interpretation. The smallest brown snake species examined remains a lizard specialist throughout its life. Unlike the larger species, it does not undergo a comparable dietary shift and does not develop the adult procoagulant venom profile. Its venom remains dominated by neurotoxins, and the researchers detected no parallel increase in procoagulant activity. This contrast suggests that the developmental switch is not an unavoidable feature of brown snake growth. It is associated with the ecological transition to mammal predation. If body size alone were responsible, the lizard specialist might be expected to acquire the same adult venom machinery as it matured. Instead, its stable diet is accompanied by stable venom function. The comparison provides a compelling example of how natural selection can tune developmental biology differently in closely related species occupying distinct feeding niches.
To investigate these patterns, the research team combined transcriptomic, proteomic and biochemical approaches. Transcriptomic analyses measure the RNA molecules being produced by cells and reveal which toxin genes are active in the venom gland at different life stages. Proteomic analyses, including high-performance liquid chromatography coupled with high-resolution tandem mass spectrometry, identify the proteins actually present in the secreted venom. This distinction matters because a gene can be transcribed without its protein product accumulating in venom, and a protein’s presence does not necessarily reveal how much biological activity it retains. The team also used sequence comparisons and phylogenetic analyses to examine the evolutionary relationships of the toxin families, while coagulation experiments tested how venoms affected mammalian blood-clotting reactions. Prothrombin cleavage assays, for example, can reveal whether venom components directly promote the formation of thrombin or disrupt the normal processing of clotting proteins. By integrating these layers of evidence, the researchers showed that the developmental pattern is molecularly coordinated and functionally meaningful.
The results also carry implications for medical science. Brown snake venom has long been associated with severe coagulopathy in human victims, a condition in which the blood-clotting system becomes dangerously abnormal. Understanding which toxin families appear at different developmental stages may improve the interpretation of venom variation and help researchers refine antivenom strategies. Antivenoms are produced by generating antibodies against venom components, but the composition of venom can differ among species, populations and life stages. If juvenile and adult snakes express substantially different toxin repertoires, exposure to a young snake may not be immunologically identical to exposure to an adult. The discovery may also help identify new molecular tools for studying coagulation. Venom-derived enzymes and inhibitors can reveal how clotting pathways operate by selectively activating or blocking particular reactions. Such compounds have historically informed the development of diagnostic reagents and pharmacological agents, although the toxic effects of the native venoms make clinical exposure a medical emergency rather than a therapeutic opportunity.
Perhaps the broader message is that major ecological innovations can emerge through changes in when genes are switched on, not only through changes in the genes themselves. The brown snake’s developmental trajectory resembles a biological handover between two hunting strategies. Early in life, a neurotoxic system supports the capture of reptilian prey. Later, a procoagulant system takes over as the snake enters a mammal-focused phase. The transition appears to involve several toxin families rising together, creating a functional transformation greater than the contribution of any single gene. This is an example of genotype-to-phenotype mapping in action: regulatory changes in the genome alter toxin expression, altered expression reshapes venom chemistry, and venom chemistry changes the animal’s capacity to capture prey. The study therefore connects molecular biology with life-history evolution in a particularly direct way. It shows how a snake’s changing body, diet and venom can be parts of one coordinated developmental program.
The findings may also change how scientists think about venom diversity across the animal kingdom. Venom systems are often treated as stable species traits, but many venomous animals produce different secretions depending on age, sex, season, diet or geography. In Australian brown snakes, age-related variation is not a minor adjustment. It represents a functional reorganization with consequences for both prey capture and human envenoming. The research suggests that examining venom only in adults can conceal important stages of its evolution and development. It also highlights the value of studying species that appear closely related but differ in ecology. The lizard-specialist brown snake acts as a biological control, revealing that the adult mammal-targeting venom is linked to prey choice rather than simply to maturation. Future studies will need to determine how the developmental program is regulated, whether environmental cues influence its timing and how widespread similar prey-linked venom transitions are among snakes. For now, the Australian brown snakes provide a striking case in which growing up means not only becoming larger, but changing the molecular logic of attack.
Subject of Research: Developmental changes in venom gene expression, venom function and prey preference in Australian brown snakes.
Article Title: A developmental shift in venom toxin expression underpins a major prey switch in Australian brown snakes
Article References: van Thiel, J., Smith, C. F., Kazandjian, T. D. et al. “A developmental shift in venom toxin expression underpins a major prey switch in Australian brown snakes.” BMC Biology (2026).
Image Credits: AI Generated
DOI: 10.1186/s12915-026-02699-0
Keywords: Gene regulation; genotype–phenotype mapping; life-history traits; extended phenotype; phenotypic plasticity; snake venom; venom composition.
